Abstract
HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Current HIV Research
Title: Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment
Volume: 7 Issue: 5
Author(s): Eoin J. Cotter, Peter P. Doran and William G. Powderly
Affiliation:
Abstract: HIV-1 exerts its most profound effects through destruction of the hosts immune responses specifically through targeting of the T-lymphocyte populations. In addition to its primary immune target, HIV-1 also targets cells of the nervous, skeletal and vascular system. There is emerging evidence to suggest that HIV-1 may, in part at least, affect these diverse tissues by impairing the homeostatic production of terminally differentiated cells from stem and progenitor cell populations. The interaction between HIV-1 and stem cell populations may serve to underpin the diverse nonimmunological effects of HIV-1. This review deals with the effect of HIV-1 infection on a number of progenitor cell types, with emphasis on delineating mechanisms of HIVs destructive effect on the body. Modification of these effects may represent novel avenues for exploration in our search for clinical interventions.
Export Options
About this article
Cite this article as:
Cotter J. Eoin, Doran P. Peter and Powderly G. William, Progenitor Cell Types in HIV-1 Infection: Bioactivity and Emerging Targets for Treatment, Current HIV Research 2009; 7 (5) . https://dx.doi.org/10.2174/157016209789346282
DOI https://dx.doi.org/10.2174/157016209789346282 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
What Animal Models are Best to Test Novel Rheumatoid Arthritis Therapies?
Current Rheumatology Reviews Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Current Pharmaceutical Design Par-4 for Molecular Therapy of Prostate Cancer
Current Drug Targets The Potential for Genetically Altered Microglia to Influence Glioma Treatment
CNS & Neurological Disorders - Drug Targets State-of-the-Art Lentiviral Vectors for Research Use: Risk Assessment and Biosafety Recommendations
Current Gene Therapy Ebola Virus Altered Innate and Adaptive Immune Response Signalling Pathways: Implications for Novel Therapeutic Approaches
Infectious Disorders - Drug Targets Patent Annotations
Recent Patents on Anti-Infective Drug Discovery In silico Designing and Screening of Lead Compounds to NS5-Methyltransferase of Dengue Viruses
Medicinal Chemistry Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Current HIV Research Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research Ex Vivo Liver – Directed Gene Therapy for the Treatment of Metabolic Diseases: Advances in Hepatocyte Transplantation and Retroviral Vectors
Current Gene Therapy Multi-Target Drugs for Neglected Diseases
Current Pharmaceutical Design Crystallization and Preliminary Crystallographic Analysis of Allograft Inflammatory Factor 1
Protein & Peptide Letters Synthesis and Mosquiticidal Activity of Novel Hydrazone Containing Pyrimidine Derivatives against Aedes aegypti
Letters in Drug Design & Discovery Biochemical Markers of Autoimmune Diseases of the Nervous System
Current Pharmaceutical Design Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target
Current Medicinal Chemistry DNA Vaccines for Prostate Cancer
Current Cancer Therapy Reviews Drusen in the Peripheral Retina of the Alzheimer’s Eye
Current Alzheimer Research Recent Developments in Particulate-Based Vaccines
Recent Patents on Drug Delivery & Formulation Sodium Lauryl Sulfate, a Microbicide Effective Against Enveloped and Nonenveloped Viruses
Current Drug Targets